1.18USD
122.87 MUSD
1.57 BUSD
112.01 M
About Globus Medical, Inc.
Sector
Industry
CEO
Daniel T. Scavilla
Website
Headquarters
Audubon
Employees (FY)
5 K
Founded
2003
ISIN
US3795772082
FIGI
BBG002V87SD0
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GMED is 51.20 USD — it has decreased by 1.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Globus Medical, Inc. stocks are traded under the ticker GMED.
Globus Medical, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Globus Medical, Inc. has a max estimate of 83.00 USD and a min estimate of 55.00 USD.
GMED earnings for the last quarter are 0.57 USD whereas the estimation was 0.54 USD which accounts for 5.57% surprise. Estimated earnings for the next quarter are 0.58 USD. See more details about Globus Medical, Inc. earnings.
Globus Medical, Inc. revenue for the last quarter amounts to 383.64 M USD despite the estimated figure of 306.78 M USD. In the next quarter revenue is expected to reach 608.77 M USD.
Yes, you can track Globus Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Globus Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 5.00 K employees. See our rating of the largest employees — is Globus Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Globus Medical, Inc. EBITDA is 349.32 M USD, and current EBITDA margin is 22.10%. See more stats in Globus Medical, Inc. financial statements.